nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.254	0.315	CbGbCtD
Diphenhydramine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.121	0.15	CbGbCtD
Diphenhydramine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0804	0.0997	CbGbCtD
Diphenhydramine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0664	0.0822	CbGbCtD
Diphenhydramine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0507	0.0629	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0444	0.055	CbGbCtD
Diphenhydramine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0425	0.0526	CbGbCtD
Diphenhydramine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0406	0.0502	CbGbCtD
Diphenhydramine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0344	0.0427	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0231	0.0286	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0198	0.0246	CbGbCtD
Diphenhydramine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0182	0.0225	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0112	0.0138	CbGbCtD
Diphenhydramine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00115	0.215	CrCbGaD
Diphenhydramine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00107	0.2	CrCbGaD
Diphenhydramine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.000709	0.133	CrCbGaD
Diphenhydramine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000619	0.0033	CcSEcCtD
Diphenhydramine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.0033	CcSEcCtD
Diphenhydramine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000611	0.00326	CcSEcCtD
Diphenhydramine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.00322	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000602	0.00321	CcSEcCtD
Diphenhydramine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0006	0.0032	CcSEcCtD
Diphenhydramine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000599	0.0032	CcSEcCtD
Diphenhydramine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000599	0.0032	CcSEcCtD
Diphenhydramine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000598	0.00319	CcSEcCtD
Diphenhydramine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000595	0.00317	CcSEcCtD
Diphenhydramine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000595	0.00317	CcSEcCtD
Diphenhydramine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000589	0.00314	CcSEcCtD
Diphenhydramine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000589	0.00314	CcSEcCtD
Diphenhydramine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000588	0.00314	CcSEcCtD
Diphenhydramine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000587	0.00313	CcSEcCtD
Diphenhydramine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000583	0.00311	CcSEcCtD
Diphenhydramine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000583	0.00311	CcSEcCtD
Diphenhydramine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000581	0.0031	CcSEcCtD
Diphenhydramine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00058	0.00309	CcSEcCtD
Diphenhydramine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000577	0.00308	CcSEcCtD
Diphenhydramine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000576	0.00307	CcSEcCtD
Diphenhydramine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000576	0.00307	CcSEcCtD
Diphenhydramine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000576	0.00307	CcSEcCtD
Diphenhydramine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000576	0.00307	CcSEcCtD
Diphenhydramine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000574	0.00306	CcSEcCtD
Diphenhydramine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000571	0.00305	CcSEcCtD
Diphenhydramine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000571	0.00305	CcSEcCtD
Diphenhydramine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000571	0.00305	CcSEcCtD
Diphenhydramine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000569	0.00303	CcSEcCtD
Diphenhydramine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000567	0.00302	CcSEcCtD
Diphenhydramine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000567	0.00302	CcSEcCtD
Diphenhydramine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00302	CcSEcCtD
Diphenhydramine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000564	0.00301	CcSEcCtD
Diphenhydramine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000562	0.003	CcSEcCtD
Diphenhydramine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00055	0.00294	CcSEcCtD
Diphenhydramine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000546	0.00291	CcSEcCtD
Diphenhydramine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000546	0.00291	CcSEcCtD
Diphenhydramine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000545	0.00291	CcSEcCtD
Diphenhydramine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.0029	CcSEcCtD
Diphenhydramine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.00284	CcSEcCtD
Diphenhydramine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000533	0.00284	CcSEcCtD
Diphenhydramine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000531	0.00283	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00053	0.00283	CcSEcCtD
Diphenhydramine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000526	0.00281	CcSEcCtD
Diphenhydramine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000526	0.00281	CcSEcCtD
Diphenhydramine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00052	0.00277	CcSEcCtD
Diphenhydramine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000516	0.00275	CcSEcCtD
Diphenhydramine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000514	0.00274	CcSEcCtD
Diphenhydramine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.00273	CcSEcCtD
Diphenhydramine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000509	0.00272	CcSEcCtD
Diphenhydramine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000506	0.0027	CcSEcCtD
Diphenhydramine—Chills—Etoposide—peripheral nervous system neoplasm	0.000495	0.00264	CcSEcCtD
Diphenhydramine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000494	0.00264	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00262	CcSEcCtD
Diphenhydramine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000491	0.00262	CcSEcCtD
Diphenhydramine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00261	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.00259	CcSEcCtD
Diphenhydramine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000479	0.00256	CcSEcCtD
Diphenhydramine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000479	0.00255	CcSEcCtD
Diphenhydramine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000475	0.00254	CcSEcCtD
Diphenhydramine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000475	0.00254	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000474	0.00253	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00251	CcSEcCtD
Diphenhydramine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000471	0.00251	CcSEcCtD
Diphenhydramine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000469	0.0025	CcSEcCtD
Diphenhydramine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.0025	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000468	0.0025	CcSEcCtD
Diphenhydramine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.00249	CcSEcCtD
Diphenhydramine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000461	0.00246	CcSEcCtD
Diphenhydramine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000457	0.00244	CcSEcCtD
Diphenhydramine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00242	CcSEcCtD
Diphenhydramine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00242	CcSEcCtD
Diphenhydramine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000453	0.00242	CcSEcCtD
Diphenhydramine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000453	0.00242	CcSEcCtD
Diphenhydramine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000452	0.00241	CcSEcCtD
Diphenhydramine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00241	CcSEcCtD
Diphenhydramine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000448	0.00239	CcSEcCtD
Diphenhydramine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00238	CcSEcCtD
Diphenhydramine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00238	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.00238	CcSEcCtD
Diphenhydramine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00236	CcSEcCtD
Diphenhydramine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000442	0.00236	CcSEcCtD
Diphenhydramine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00234	CcSEcCtD
Diphenhydramine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00234	CcSEcCtD
Diphenhydramine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000438	0.00233	CcSEcCtD
Diphenhydramine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00233	CcSEcCtD
Diphenhydramine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000435	0.00232	CcSEcCtD
Diphenhydramine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.00231	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000432	0.0023	CcSEcCtD
Diphenhydramine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00229	CcSEcCtD
Diphenhydramine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000425	0.00227	CcSEcCtD
Diphenhydramine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00225	CcSEcCtD
Diphenhydramine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00225	CcSEcCtD
Diphenhydramine—Rash—Topotecan—peripheral nervous system neoplasm	0.000421	0.00225	CcSEcCtD
Diphenhydramine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000421	0.00224	CcSEcCtD
Diphenhydramine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000421	0.00224	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000419	0.00223	CcSEcCtD
Diphenhydramine—Headache—Topotecan—peripheral nervous system neoplasm	0.000418	0.00223	CcSEcCtD
Diphenhydramine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000418	0.00223	CcSEcCtD
Diphenhydramine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000418	0.00223	CcSEcCtD
Diphenhydramine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000418	0.00223	CcSEcCtD
Diphenhydramine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000417	0.00223	CcSEcCtD
Diphenhydramine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000417	0.00223	CcSEcCtD
Diphenhydramine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000417	0.00223	CcSEcCtD
Diphenhydramine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000416	0.00222	CcSEcCtD
Diphenhydramine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000416	0.00222	CcSEcCtD
Diphenhydramine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000415	0.00221	CcSEcCtD
Diphenhydramine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000415	0.00221	CcSEcCtD
Diphenhydramine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00221	CcSEcCtD
Diphenhydramine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000414	0.00221	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00221	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000414	0.00221	CcSEcCtD
Diphenhydramine—Rash—Melphalan—peripheral nervous system neoplasm	0.000412	0.0022	CcSEcCtD
Diphenhydramine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000412	0.0022	CcSEcCtD
Diphenhydramine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00218	CcSEcCtD
Diphenhydramine—Reboxetine—ABCB1—peripheral nervous system neoplasm	0.000407	0.0762	CrCbGaD
Diphenhydramine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00213	CcSEcCtD
Diphenhydramine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00213	CcSEcCtD
Diphenhydramine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000397	0.00212	CcSEcCtD
Diphenhydramine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000395	0.00211	CcSEcCtD
Diphenhydramine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000394	0.0021	CcSEcCtD
Diphenhydramine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.0021	CcSEcCtD
Diphenhydramine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000389	0.00207	CcSEcCtD
Diphenhydramine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000389	0.00207	CcSEcCtD
Diphenhydramine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000384	0.00205	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000384	0.00205	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000383	0.00204	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000379	0.00202	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000374	0.00199	CcSEcCtD
Diphenhydramine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000372	0.00198	CcSEcCtD
Diphenhydramine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000371	0.00198	CcSEcCtD
Diphenhydramine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000366	0.00195	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00193	CcSEcCtD
Diphenhydramine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00192	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000357	0.0019	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000353	0.00188	CcSEcCtD
Diphenhydramine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000353	0.00188	CcSEcCtD
Diphenhydramine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000352	0.00188	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000348	0.00186	CcSEcCtD
Diphenhydramine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000347	0.00185	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00184	CcSEcCtD
Diphenhydramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000344	0.00184	CcSEcCtD
Diphenhydramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.00183	CcSEcCtD
Diphenhydramine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000342	0.00182	CcSEcCtD
Diphenhydramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000341	0.00182	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000338	0.0018	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000338	0.0018	CcSEcCtD
Diphenhydramine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000335	0.00179	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00178	CcSEcCtD
Diphenhydramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00177	CcSEcCtD
Diphenhydramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000331	0.00177	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00176	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00174	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000323	0.00172	CcSEcCtD
Diphenhydramine—Toremifene—ABCB1—peripheral nervous system neoplasm	0.000323	0.0604	CrCbGaD
Diphenhydramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00172	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00172	CcSEcCtD
Diphenhydramine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00032	0.00171	CcSEcCtD
Diphenhydramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.0017	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.0017	CcSEcCtD
Diphenhydramine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00169	CcSEcCtD
Diphenhydramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00169	CcSEcCtD
Diphenhydramine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00168	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00167	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000311	0.00166	CcSEcCtD
Diphenhydramine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000308	0.00164	CcSEcCtD
Diphenhydramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00164	CcSEcCtD
Diphenhydramine—Rash—Vincristine—peripheral nervous system neoplasm	0.000305	0.00163	CcSEcCtD
Diphenhydramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000305	0.00163	CcSEcCtD
Diphenhydramine—Headache—Vincristine—peripheral nervous system neoplasm	0.000303	0.00162	CcSEcCtD
Diphenhydramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00159	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00159	CcSEcCtD
Diphenhydramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000293	0.00156	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00154	CcSEcCtD
Diphenhydramine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000287	0.00153	CcSEcCtD
Diphenhydramine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000281	0.0015	CcSEcCtD
Diphenhydramine—Clomifene—ABCB1—peripheral nervous system neoplasm	0.000279	0.0522	CrCbGaD
Diphenhydramine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000278	0.00148	CcSEcCtD
Diphenhydramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000272	0.00145	CcSEcCtD
Diphenhydramine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00027	0.00144	CcSEcCtD
Diphenhydramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00027	0.00144	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000268	0.00143	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00142	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00141	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00139	CcSEcCtD
Diphenhydramine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000259	0.00138	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00137	CcSEcCtD
Diphenhydramine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00136	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00135	CcSEcCtD
Diphenhydramine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000249	0.00133	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00132	CcSEcCtD
Diphenhydramine—Rash—Etoposide—peripheral nervous system neoplasm	0.000247	0.00132	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000247	0.00132	CcSEcCtD
Diphenhydramine—Headache—Etoposide—peripheral nervous system neoplasm	0.000246	0.00131	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.0013	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00129	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00129	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00127	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00125	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00124	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000233	0.00124	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00122	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000224	0.0012	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00119	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00118	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00117	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00115	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00115	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00114	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00113	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00112	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00111	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000205	0.0011	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00109	CcSEcCtD
Diphenhydramine—Bepridil—ABCB1—peripheral nervous system neoplasm	0.000203	0.0379	CrCbGaD
Diphenhydramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00106	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00106	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00106	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00105	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00105	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00104	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00103	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00103	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00102	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00101	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00101	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000188	0.001	CcSEcCtD
Diphenhydramine—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.000186	0.0349	CrCbGaD
Diphenhydramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000981	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000974	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000966	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000964	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000955	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000943	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000935	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000931	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000927	CcSEcCtD
Diphenhydramine—Phenytoin—ABCB1—peripheral nervous system neoplasm	0.000169	0.0316	CrCbGaD
Diphenhydramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000894	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000862	CcSEcCtD
Diphenhydramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000841	CcSEcCtD
Diphenhydramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000802	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000778	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000775	CcSEcCtD
Diphenhydramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000745	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000742	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000739	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000738	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000734	CcSEcCtD
Diphenhydramine—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000135	0.0252	CrCbGaD
Diphenhydramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000717	CcSEcCtD
Diphenhydramine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000696	CcSEcCtD
Diphenhydramine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.00013	0.0243	CrCbGaD
Diphenhydramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00069	CcSEcCtD
Diphenhydramine—Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.000129	0.0241	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—peripheral nervous system neoplasm	0.000129	0.0241	CrCbGaD
Diphenhydramine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000684	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000683	CcSEcCtD
Diphenhydramine—Methadone—ABCB1—peripheral nervous system neoplasm	0.000128	0.0239	CrCbGaD
Diphenhydramine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000679	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000644	CcSEcCtD
Diphenhydramine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.0001	0.0187	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	9.94e-05	0.0186	CrCbGaD
